IRIS UniCatt

Iorio, Raffaele
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.501
EU - Europa 3.472
AS - Asia 1.458
SA - Sud America 338
AF - Africa 49
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 5
Totale 8.835
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.447
DE - Germania 1.430
SE - Svezia 572
CN - Cina 555
SG - Singapore 489
IT - Italia 348
BR - Brasile 293
UA - Ucraina 273
FR - Francia 227
IE - Irlanda 157
GB - Regno Unito 143
IN - India 125
FI - Finlandia 96
ID - Indonesia 94
RU - Federazione Russa 73
TR - Turchia 40
BE - Belgio 34
CA - Canada 33
KR - Corea 30
CI - Costa d'Avorio 29
PL - Polonia 23
AT - Austria 21
HK - Hong Kong 20
JP - Giappone 16
CH - Svizzera 15
NL - Olanda 15
IQ - Iraq 12
MX - Messico 12
AU - Australia 11
CO - Colombia 11
IR - Iran 11
AR - Argentina 10
VN - Vietnam 10
EC - Ecuador 8
MA - Marocco 8
BD - Bangladesh 7
CL - Cile 7
LT - Lituania 6
AZ - Azerbaigian 5
LV - Lettonia 5
PK - Pakistan 5
A2 - ???statistics.table.value.countryCode.A2??? 4
BY - Bielorussia 4
CZ - Repubblica Ceca 4
EG - Egitto 4
ES - Italia 4
KZ - Kazakistan 4
PT - Portogallo 4
RO - Romania 4
SA - Arabia Saudita 4
VE - Venezuela 4
IL - Israele 3
KG - Kirghizistan 3
LK - Sri Lanka 3
MD - Moldavia 3
OM - Oman 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
BG - Bulgaria 2
BO - Bolivia 2
GR - Grecia 2
JM - Giamaica 2
JO - Giordania 2
MY - Malesia 2
TH - Thailandia 2
TN - Tunisia 2
ZA - Sudafrica 2
AL - Albania 1
BZ - Belize 1
CR - Costa Rica 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
EU - Europa 1
GE - Georgia 1
HU - Ungheria 1
KE - Kenya 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LU - Lussemburgo 1
MM - Myanmar 1
MU - Mauritius 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PA - Panama 1
PE - Perù 1
PH - Filippine 1
PR - Porto Rico 1
PY - Paraguay 1
RS - Serbia 1
TM - Turkmenistan 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
Totale 8.835
Salva come PNG Salva come JPEG
Città #
Chandler 670
Ashburn 350
Singapore 320
Jacksonville 198
Ann Arbor 179
Dublin 150
New York 146
San Mateo 130
Nanjing 102
Nürnberg 100
Jakarta 93
Dearborn 83
Woodbridge 83
Wilmington 67
Chicago 65
Houston 58
Milan 55
Marseille 50
Bremen 49
Los Angeles 49
Cattolica 48
Boston 47
Frankfurt am Main 44
Rome 44
Moscow 43
North Bergen 43
Hefei 39
Princeton 39
Lawrence 37
Munich 36
Redwood City 35
Brussels 34
Nanchang 33
Izmir 32
Beijing 31
Düsseldorf 30
Redmond 30
Seoul 30
Abidjan 29
Norwalk 28
Seattle 28
Nuremberg 25
Hangzhou 24
Helsinki 23
São Paulo 23
Mountain View 20
Shenyang 20
Ottawa 19
Pune 19
Detroit 18
Hong Kong 18
Shanghai 18
Boardman 17
University Park 17
Trieste 16
Monza 15
Turku 15
Changsha 14
Fairfield 14
Leawood 14
London 14
Tianjin 14
Hebei 12
Roubaix 12
Wroclaw 12
Falkenstein 10
Washington 10
Bexley 9
Kunming 9
Portsmouth 9
Santa Clara 9
Belo Horizonte 8
Campinas 8
Des Moines 8
Guangzhou 8
Jiaxing 8
Paris 8
Rio de Janeiro 8
Salvador 8
San Francisco 8
Zhengzhou 8
Zurich 8
Buffalo 7
Cambridge 7
Naples 7
Stockholm 7
Xi'an 7
Amsterdam 6
Indiana 6
The Dalles 6
Verona 6
Vienna 6
Atlanta 5
Baku 5
Brooklyn 5
Council Bluffs 5
Falls Church 5
Fremont 5
Ho Chi Minh City 5
Hyderabad 5
Totale 4.419
Salva come PNG Salva come JPEG
Nome #
Circulating CD56dim NK cells expressing perforin are increased in progressive multiple sclerosis 219
pSTAT1, pSTAT3, and T-bet as markers of disease activity in chronic inflammatory demyelinating polyradiculoneuropathy. 193
T-bet, pSTAT1 and pSTAT3 expression in peripheral blood mononuclear cells during pregnancy correlates with post-partum activation of multiple sclerosis. 176
CD8(+) T Cells in Facioscapulohumeral Muscular Dystrophy Patients with Inflammatory Features at Muscle MRI 174
T-bet and pSTAT1 expression in peripheral blood mononuclear cells from coeliac disease patients: new markers of disease activity 166
Multiple Sclerosis attacks triggered by hyperprolactinemia 159
Distinctive clinical and neuroimaging characteristics of longitudinally extensive transverse myelitis associated with aquaporin-4 autoantibodies 159
Acute necrotizing Encephalopathy during novel influenza A (H1N!) virus infection 153
The effect of disease activity on leptin, leptin receptor and suppressor of cytokine signalling-3 expression in relapsing-remitting multiple sclerosis. 149
Poly-autoimmunity in patients with myasthenia gravis: A single-center experience 147
Cerebellar degeneration associated with mGluR1 autoantibodies as a paraneoplastic manifestation of prostate adenocarcinoma 146
Glucocorticoid treatment reduces T-bet and pSTAT1 expression in mononuclear cells from relapsing remitting multiple sclerosis patients. 139
Assessment of neurological manifestations in hospitalized patients with COVID-19 139
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 138
Increased expression of T-bet in circulating B cells from a patient with multiple sclerosis and celiac disease 136
Refractory generalized seizures and cerebellar ataxia associated with anti-GAD antibodies responsive to immunosuppressive treatment. 135
A Case of Hemiabdominal Myoclonus 134
Overcoming challenges in the diagnosis and treatment of myasthenia gravis 129
Epstein-Barr virus antibodies in serum and cerebrospinal fluid from Multiple Sclerosis, Chronic Inflammatory Demyelinating Polyradiculoneuropathy and Amyotrophic Lateral 128
Overcoming challenges in the diagnosis and treatment of myasthenia gravis 127
Copper deficiency myelopathy: A report of two cases 122
Circulating CD8+CD56-Perforin+ T cells are increased in Multiple Sclerosis patients 121
Remission of myasthenia gravis with MuSK antibodies during ruxolitinib treatment 121
Prognostic relevance of quantitative and longitudinal MOG antibody testing in patients with MOGAD: a multicentre retrospective study 120
A b3 type-thymoma in a 7-year-old child with myasthenia gravis 119
Replay to Influenza A (H1N1) in cerebrospinal fluid sample and encephalopathy by Sandoval-Gutiérrez JM, Arcos M, Alva L, Volkow P, T Ferrari T, Quiñones F, Vázquez-Pérez J, Ormsby JE, Hanssen F, Reséndiz A, Alcántara P, Pérez Padilla R, Bautista E. 118
CD8(+)Foxp3(+) T cells in peripheral blood of relapsing-remitting multiple sclerosis patients 116
Efficacy and safety of rituximab for myasthenia gravis: a systematic review and meta-analysis 115
Brainstem and spinal cord involvement in a paraneoplastic syndrome associated with anti-Yo antibody and breast cancer. 111
Type 1 immune response in progressive Multiple Sclerosis 109
Progressive multifocal leukoencephalopathy in a patient with Franklin disease and hypogammaglobulinemia. 108
Increased CD4(+)CD25(+)Foxp3(+) T Cells in Peripheral Blood of Celiac Disease Patients: Correlation with Dietary Treatment. 107
3,4-Diaminopyridine may improve myasthenia gravis with MuSK antibodies 107
CD4+pSTAT3+ and CD8+T-bet+ T cells accumulate in peripheral blood during NZB treatment 105
Long-Lasting Rituximab-Induced Reduction of Specific—But Not Total—IgG4 in MuSK-Positive Myasthenia Gravis 104
IL17 and IFNgamma production by peripheral blood mononuclear cells from clinically isolated syndrome to secondary progressive multiple sclerosis. 102
Sleep disorder associated with antibodies to IgLON5: parasomnia or agrypnia? 100
Resolution of muscle inflammation after tumor removal in a woman with paraneoplastic dermatomyositis 99
The persistency of high levels of pSTAT3 expression in circulating CD4+ T cells from CIS patients favors the early conversion to clinically defined multiple sclerosis. 99
Distinct lymphocytes subsets in IgM-related neuropathy: clinical-immunological correlations 98
Breastfeeding and multiple sclerosis 97
Teaching NeuroImages: Transient mutism associated with splenium lesion in capecitabine-induced leukoencephalopathy 95
Pattern of ocular involvement in myasthenia gravis with MuSK antibodies 93
Myasthenia gravis with antibodies to MuSK: an update 92
Clinical characteristics and outcome of patients with autoimmune encephalitis: clues for paraneoplastic etiology 92
Clinical features and outcome of patients with autoimmune cerebellar ataxia evaluated with the Scale for the Assessment and Rating of Ataxia 91
Myasthenia gravis with presynaptic neurophysiological signs: Two case reports and literature review 90
Efficacy and safety of rituximab therapy in neuromyelitis optica spectrum disorders: A systematic review and meta-analysis 89
Multiple sclerosis attacks triggered by hyperprolactinemia 88
SIADH in a patient with sensory ataxic neuropathy with anti-disialosyl antibodies (CANOMAD) 88
A Case of Hemiabdominal Myoclonus 88
Post-Encephalitic Parkinsonism and Sleep Disorder Responsive to Immunological Treatment: A Case Report 88
Clinical and immunological characteristics of the spectrum of GFAP autoimmunity: a case series of 22 patients 86
Regulatory T cells fail to suppress CD4(+)T-bet(+) T cells in relapsing multiple sclerosis patients 85
Focal hyperhidrosis in tumefactive Multiple Sclerosis 85
Acetylcholine receptor antibody positivity rate in ocular myasthenia gravis: a matter of age? 85
Lower motor neuron involvement in longitudinally extensive transverse myelitis with and without aquaporin-4 antibodies 84
Gemelli decision tree Algorithm to Predict the need for home monitoring or hospitalization of confirmed and unconfirmed COVID-19 patients (GAP-Covid19): preliminary results from a retrospective cohort study 83
Glioblastoma in multiple sclerosis: a case report 83
gc) Increased CD4+CD25+Foxp3+ T cells in peripheral blood of celiac disease patients: correlation with dietary treatment. 81
The detection of neural autoantibodies in patients with antiepileptic-drug-resistant epilepsy predicts response to immunotherapy 81
Imaging Features of Varicella Zoster Virus Cranial Multiple Mononeuropathies 81
Post-Encephalitic Parkinsonism and Sleep Disorder Responsive to Immunological Treatment: A Case Report 80
gc)Increased expression of T-bet in circulating B cells from a patient with multiple sclerosis and celiac disease 77
Overcoming challenges in the diagnosis and treatment of myasthenia gravis 76
Gastrointestinal symptoms and digestive comorbidities in an Italian cohort of patients with COVID-19 75
gc) T-bet and pSTAT-1 expression in PBMC from coeliac disease patients: new markers of disease activity. 73
Nine syndrome 71
Neuromyelitis optica spectrum disorder as a paraneoplastic manifestation of lung adenocarcinoma expressing aquaporin-4 65
Movement disorders phenomenology in focal motor seizures 65
pSTAT1, pSTAT3, and T-bet expression in peripheral blood mononuclear cells from relapsing-remitting multiple sclerosis patients correlates with disease activity 64
Tuberculous nephritis accompanying neuromyelitis optica: causal or coincidental association? 64
Controversies in Ocular Myasthenia Gravis 63
Toxic leukoencephalopathy after intravenous heroin injection: a case with clinical and radiological reversibility 53
Myasthenia gravis associated with muscle-specific kinase antibodies in a patient treated with interleukin-17 inhibitor 50
Myasthenia gravis: the changing treatment landscape in the era of molecular therapies 50
Diagnostics of paraneoplastic neurological syndromes 49
A score that predicts aquaporin-4 IgG positivity in patients with longitudinally extensive transverse myelitis 46
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 45
Management of antibody-mediated autoimmune encephalitis in adults and children: literature review and consensus-based practical recommendations 45
Diagnostics of autoimmune encephalitis associated with antibodies against neuronal surface antigens 43
Isolated Memory Loss in Anti-NMDAR Encephalitis 41
Real-world application of the updated diagnostic criteria for paraneoplastic neurological syndromes 35
Teaching Video NeuroImage: Bilateral Eyelid Opening Apraxia in a Patient With Top of the Basilar Syndrome 35
Cancer Frequency in MuSK Myasthenia Gravis and Histological Evidence of Paraneoplastic Etiology 33
Grading the severity of autoimmune encephalitis: Advances and pitfalls 32
Immunotherapy improves sleep and cognitive impairment in anti-IgLON5 encephalopathy 31
Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study 30
Pseudoperipheral tongue weakness 30
Clinical and neuroimaging characteristics of MOG autoimmunity in children with acquired demyelinating syndromes 30
Concordance between radioimmunoassay and fixed cell-based assay in subjects without myasthenia gravis: optimizing the diagnostic approach 28
Paraneoplastic neurological syndromes 27
Clinical Reasoning: A 55-year-old woman presenting with ataxia and numbness 1 year after ileum resection 27
Neuromyelitis optica and the evolving spectrum of autoimmune aquaporin-4 channelopathies 26
Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study 25
Corticospinal tract hyperintensity in patients with LGI1-antibody encephalitis and other central nervous system disorders with neuroglial antibodies 23
Assessment of neurological manifestations in hospitalized patients with COVID-19 22
Clinically relevant increases in serum neurofilament light chain and glial fibrillary acidic protein in patients with Susac syndrome 21
Epilepsia Partialis Continua as a manifestation of aquaporin-4 autoimmunity 20
Cervical lymph nodes and ovarian teratomas as germinal centres in NMDA receptor-Antibody encephalitis 19
Totale 8.861
Salva come PNG Salva come JPEG
Categoria #
all - tutte 37.594
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.594
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202064 0 0 0 0 0 0 0 0 0 0 0 64
2020/2021677 58 59 8 66 86 34 82 23 68 42 136 15
2021/2022794 75 47 24 74 41 18 22 101 36 61 121 174
2022/20231.832 196 243 144 302 98 223 98 158 239 52 51 28
2023/20241.018 36 242 36 111 25 185 69 44 18 29 112 111
2024/20252.004 36 79 144 79 115 58 96 97 344 198 457 301
Totale 8.996